March 2011

Ready to Take a Risk Again?

March 7, 2011

As agencies, we share a responsibility to experiment and push boundaries to drive our brands’ — and our Clients — success. Media channels and offerings are varied and increasing every day. The potential for innovation within the digital media sphere is such that you can create what you need versus relying upon pre-built vehicles. Many […]

What Advances in Technology did to Healthcare Communications

March 7, 2011

Welcome to the 21st century — a time period where advances in electronic media have opened new opportunities to communicate with physicians and patients, explore ­creativity, and help bring the health care world closer together. But as we’ll see, there are some things in our business that even the best technology can’t do. Capturing the […]

Reach More Potential Patients

March 7, 2011

In the year ending October 2010, more than $4.4 billion was spent to promote drugs directly to consumers (DTC) through television, magazine, newspaper, Internet, radio, and outdoor advertisements. Although spending was higher when there were more blockbusters being advertised, there are still many brands today for which DTC advertising is one of the biggest marketing […]

202020 VISION

March 7, 2011

Ogilvy CommonHealth Worldwide, part of the Ogilvy & Mather network and a WPP company, represents the largest assembly of creative talent in the world of healthcare communications with 64 offices across 36 countries. { For more information visit ogilvychww.com. To request the full version of the 202020 VISION report, please contact 202020@ogilvy.com. hat we know […]

SHOWCASE FEATURE: Pharma Advertising: The 3.0 Version

March 7, 2011

According to Ernst & Young’s Progressions 2011 report, in the world of Pharma 3.0, success will be based not on how many drug units are sold, but on how well pharma’s market offerings improve health outcomes, putting patients and payers at the center of the model. As part of this transition, pharma companies are embracing […]

Namaste India: Growth Across the Board

March 7, 2011

India’s importance in the pharmaceutical space is indisputable. With healthcare booming, a strong medical infrastructure, lower costs, and high levels of patient recruitment and retention, India presents enormous potential. The pharmaceutical business has been growing by 12% to 13% over the past several years. According to Cutting Edge Information, this rate will increase as the […]

Thought Leaders

March 7, 2011

Ryan Abbate. President, Pacific ­Communications, a healthcare communications agency that ­offers strategic and tactical communications solutions. For more information, visit ­ ­pacific-com.com. Edward Abrahams, Ph.D. President,The Personalized ­Medicine Coalition, which brings together the academic, industrial, patient, provider, and payer communities committed to personalized medicine from all parts of the healthcare world. For more information, visit […]

Technology at the Speed of Light

March 7, 2011

The impact that the Internet and follow-on technologies have had on all areas of the life-sciences is well-documented throughout this special section, and the majority of our thought leaders have identified this as the biggest game changer in the last 10 years. Going even further, these same thought leaders believe technology — in all its […]

The End of the Arms Race

March 7, 2011

After more than a decade of crowding physicians’ offices with as many sales reps who would fit, the pendulum has swung ­dramatically in the other direction. The industry’s field ranks have been reduced dramatically, and now sales reps are crowding unemployment offices. Not just a Hired Gun Terrence Tormey CEO and President, Prevention Pharmaceuticals » […]

Everyone is Watching

March 7, 2011

The advent and growth of federal and state compliance regulations and the monitoring of those regulations have absolutely been game changers in the life-sciences industry over the last 10 years, says Peter Sandford, executive VP of NXLevel Solutions, a developer of technology-delivered learning applications. “The charge led by the OIG and DOJ in the early […]

The Patent Cliff

March 7, 2011

As companies look to fill the estimated $16 billion in annual revenue expected to be lost to generics over the next five years alone, they must become more adept at life-cycle management, pursuing viable reimbursement strategies, and developing ­evidence-based communications. If it seems as though pundits have been talking about the billions of dollars that […]

Outsourcing: The Time is Right

March 7, 2011

The recent world economic events have set the stage for the shape of the industry going forward. “As market conditions evolve, pharma companies are reducing their infrastructures and costs, resulting in a stronger reliance on vendors to meet trial objectives, timelines, and budgets,” says Jim DeSanti, CEO of PharmaVigilant, a clinical trial service provider. “Even […]

The ABCs of Marketing — Advertising, Branding, and the Customer

March 7, 2011

The ABCs of MarketingWith the introduction of DTC advertising, health information became ubiquitous, reaching consumers where they live, work, and play. “Enter technology, the Internet, place-based media, mobile devices, social media, and information now are literally available at one’s fingertips,” says Deborah Schnell, president of sales and strategic planning at Healthy Advice Networks, which provides […]

R&D Innovation: The Key to Long-Term Success

March 7, 2011

When the scientific discoveries and pipeline-building process of many successful biotechs are layered together, the results are likely to be dramatic. Experts predict there will be a number of game-changing product candidates in development in the next decade. “We view ourselves as part of the ‘multiplier effect’ of innovation emerging from biotech companies,” says Doug […]

Around the World in 3,650 Days

March 7, 2011

Some experts say globalization will be the big story. As companies expand into new geographies to increase their revenue footprint and meet unmet healthcare needs, they will leverage talent wherever it is located to deliver solutions to markets everywhere. “The current model of serving mature markets such as the United States, Europe, and Japan will […]

Business Not As Usual

March 7, 2011

A decade ago, our experts identified the need for pharmaceutical companies to begin to re-evaluate the business model in light of commercialization hurdles, a looming patent cliff, pipeline constrictions, mergers and acquisitions to name just a few game changers. Now, 10 years later some of these same experts are calling for a real change in […]

Agility: Key to Agency Success in the Future

March 7, 2011

For anybody involved in healthcare advertising, on the agency as well as the client side, the last decade has been marked by myriad changes and market factors that have impacted all aspects of the business. Client mergers and acquisitions, heightened regulatory scrutiny of messaging, more messaging channels, patient empowerment, you name it, advertising agency presidents […]

A Decade of Change

March 7, 2011

During the past decade there have been tremendous advances in science, innovation, technology, communications, and ­patient engagement. There have also been some tremendous setbacks, including major drug recalls, intensified regulatory oversight, and let’s not forget the infamous “gas-and-go” tactics employed by some members of the field force. It has been the best of times, it […]

Last Word

March 3, 2011

PV: What are some of the challenges facing ­pharmaceutical companies that technology can address? Kumar: With shrinking drug pipelines, companies are investing in better collaboration, standardization, and analytical tools to improve R&D productivity as well as their sales and marketing operations. Research departments are using software, online tools, and technology platforms for next-generation sequencing and […]

Talent Pool

March 3, 2011

Pharmaceutical POOL Dr. Robert CUDDIHY Sanofi-Aventis Adds to Diabetes Team Sanofi-Aventis U.S. has appointed Robert Cuddihy, M.D., VP, medical diabetes head in the U.S. Dr. Cuddihy is responsible for developing and executing the U.S. medical affairs strategy for Sanofi-Aventis’s diabetes division, including pharmaceuticals, devices, and other technologies. Before joining Sanofi-Aventis U.S., Dr. Cuddihy served as […]

On the Calendar

March 3, 2011

March 21-22 BioConference Live: Life Sciences PharmaVOICE is exhibiting at this event. BioConference Live, bioconferencelive.com March 21-23 Digital Marketing & ­Communications for Canadian Pharma Toronto PharmaVOICE subscribers receive a $200 discount; register using keycode PharmaVOICE Advanced Learning Institute, aliconferences.com March 27-29 PMRG 2011 Annual National ­Conference JW Desert Ridge, Phoenix PharmaVOICE is exhibiting at this […]

Social Media

March 3, 2011

Social Media Trends, Regs, and Apps Featured Briefs: Product Websites Drive Consumer Action Sidebar: Top Prescribing-Driving Sites Levitra top product website to spur consumer action Science Takes a Hit in Social Media Sanofi-Aventis Sets Ground Rules for Blogging MerckEngage Health Partnership Program Offers Patient Support Reverse Texting Improves Teen Med Adherence Tech Check – Apps […]

Tools of the Trade

March 3, 2011

FDA Basics for Industry is a Web-based resource provided by the Food and Drug Administration with the goal of helping companies save time and resources in their interactions with the agency. The website, fda.gov/FDABasicsforIndustry, provides information about the regulatory process, including information that is frequently requested by the industry. The website is part of the […]

What’s New

March 3, 2011

Through its recent acquisition of MedPage Today, a news organization serving healthcare professionals, Everyday Health has added a significant offering for healthcare professionals to its portfolio of consumer health information brands. MedPage provides healthcare professionals with peer-reviewed medical reporting and analysis through its websites and mobile applications. As part of the acquisition, MedPage’s CEO and […]

PharmaTrax

March 3, 2011

Pharmaceutical companies will see an opportunity to increase their visibility with consumers, influence health outcomes, and reduce healthcare costs while increasing revenue using digital strategies and technology, according to Top Health Industry Issues of 2011, a report published by the PricewaterhouseCoopers (PwC) Health Research Institute. In addition, the use of mobile health and wireless technologies […]

Outlet

March 3, 2011

According to a new study, media coverage of HIV/AIDS fell more than 70% in developed countries over the last two decades. The Trends in Sustainability Project — a joint project of the University of Leeds, Queen’s University Belfast, the Berlin-based Institute for Futures Studies and Technology Assessment (IZT), and Euromed Management School in Marseille, France […]

UpFront

March 3, 2011

Patent Cliff By 2016 medicines that generate sales of $133 billion for their manufacturers in the U.S. alone will be exposed to generics, including drugs worth $33.2 ­billion in 2011 that will lose patent protection in 2012, more than double this year’s figure, according to ­EvaluatePharma Ltd. Patent Expiry Risk Over Next 3 Years 2010 […]

Reader Feedback

March 3, 2011

Who Inspires You? PharmaVOICE Wants to Know! Each year the PharmaVOICE 100 is determined by the collective participation of you, our readers. This is your opportunity to recognize the people who inspire and motivate you and others; who are having the greatest influence on corporate leadership, research and development, technology, creativity, marketing, strategy, and more; […]

Letter from the Editor

March 3, 2011

Cheers! Time flies when one is having fun. And the last 10 years have been extremely fun and extremely rewarding. It’s been great getting to know so many of you throughout the life-sciences industry. Back in 2001, the term life-sciences was not common, in fact many questioned us as to what it meant. We believed, […]

FEEDBACK